Stocks · Health care · Pharmaceutical Preparations

Clene Inc.

CLNN Clue Score16
United States Fiscal year ends December CIK 0001822791 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
David J Matlin
13 Jan 2026
Director
Buy
33,333
$6.50
$216.66K
Robert Dee Etherington
30 Sep 2024
Chief Executive Officer
Buy
10,000
$4.75
$47.50K
Mark Mortenson
30 Sep 2024
Chief Science Officer
Buy
20,512
$4.75
$97.43K
David J Matlin
30 Sep 2024
Director
Buy
92,307
$4.75
$438.46K
David J Matlin
10 Nov 2023
Director
Buy
250,002
$0.41
$102.50K
Robert Dee Etherington
26 Jun 2023
Chief Executive Officer
Buy indirect
25,000
$0.81
$20.25K
John Henry Stevens
26 Jun 2023
Director
Buy
316,455
$0.80
$253.16K
David J Matlin
16 Jun 2023
Director
Buy
1,500,000
$0.80
$1.20M
Jonathon Gay
16 Jun 2023
Director
Buy indirect
105,625
$0.80
$84.50K
Alison Mosca
16 Jun 2023
Director
Buy indirect
2,394,375
$0.80
$1.92M
Chidozie Ugwumba
16 Jun 2023
10% owner
Buy indirect
7,500,000
$0.80
$6.00M
John Henry Stevens
2 Nov 2022
Director
Buy
148,515
$1.01
$150.00K
Alison Mosca
2 Nov 2022
Director
Buy indirect
792,079
$1.01
$800.00K
Chidozie Ugwumba
2 Nov 2022
Director
Buy indirect
990,099
$1.01
$1,000.00K
Jonathon Gay
2 Nov 2022
Director
Buy indirect
990,099
$1.01
$1,000.00K
David J Matlin
2 Nov 2022
Director
Buy
2,871,287
$1.01
$2.90M
John Henry Stevens
17 Aug 2022
Director
Buy
47,662
$3.85
$183.50K
David J Matlin
17 Jun 2022
Director
Buy
74,610
$2.51
$187.27K
David J Matlin
16 Jun 2022
Director
Buy
75,000
$2.50
$187.50K
David J Matlin
15 Jun 2022
Director
Buy
45,000
$2.66
$119.70K
Alison Mosca
15 Jun 2022
Director
Buy
5,000
$2.62
$13.10K
David J Matlin
14 Jun 2022
Director
Buy
51,011
$2.66
$135.69K
David J Matlin
13 Jun 2022
Director
Buy
55,000
$3.06
$168.30K
David J Matlin
6 Jun 2022
Director
Buy
50,670
$2.57
$130.22K
David J Matlin
3 Jun 2022
Director
Buy
10,000
$2.46
$24.60K
David J Matlin
27 May 2022
Director
Buy
35,000
$2.27
$79.45K
Jonathon Gay
16 May 2022
Director
Buy
10,000
$2.08
$20.80K
David J Matlin
16 May 2022
Director
Buy
181,818
$2.20
$400.00K
David J Matlin
20 Apr 2022
Director
Buy
132,891
$3.01
$400.00K
David J Matlin
29 Mar 2022
Director
Buy
8,648
$3.23
$27.93K
David J Matlin
28 Mar 2022
Director
Buy
10,000
$3.10
$31.00K
David J Matlin
24 Mar 2022
Director
Buy
20,000
$2.99
$59.80K
David J Matlin
23 Mar 2022
Director
Buy
20,000
$2.94
$58.80K
David J Matlin
21 Mar 2022
Director
Buy
35,000
$2.90
$101.50K
David J Matlin
18 Mar 2022
Director
Buy
20,000
$2.79
$55.80K
David J Matlin
1 Feb 2022
Director
Buy
101,352
$2.96
$300.00K
David J Matlin
10 Dec 2021
Director
Buy
15,000
$4.87
$73.05K
David J Matlin
9 Dec 2021
Director
Buy
40,000
$5.00
$200.00K
David J Matlin
8 Dec 2021
Director
Buy
5,000
$4.93
$24.65K
David J Matlin
16 Nov 2021
Director
Buy
20,000
$5.26
$105.20K
David J Matlin
15 Nov 2021
Director
Buy
15,000
$5.71
$85.65K
David J Matlin
12 Nov 2021
Director
Buy
10,000
$5.37
$53.70K
David J Matlin
24 May 2021
Director
Buy
207,684
$9.63
$2.00M
Alison Mosca
24 May 2021
Director
Buy indirect
51,921
$9.63
$500.00K

What was left out

Form 4 filings counted 318
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 83
Transactions with no price 0
Shares from compensation/vesting 6,971,284
Sales filed before the plan box existed 6
History held since 3 Feb 2021